Glimepiride is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome
Avandaryl is glimepiride and rosiglitazone.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Amaryl (Sanofi-Aventis); Avandaryl (GSK)
- INDICATIONS: Non-insulin dependent diabetes Type ll
- CLASS: Antidiabetic, Hypoglycemic (antihyperglycemic) agent, Sulfonylurea
- HALF-LIFE: 5–9 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on this DRUG REVIEW ARTICLE tab (above) to see a review of glimepiride in the Informa Healthcare journal Expert Opinion on Drug Safety
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 11/02/2023
